Document Detail

Management of neonatal purpura fulminans with severe protein C deficiency.
MedLine Citation:
PMID:  16820665     Owner:  NLM     Status:  MEDLINE    
Neonatal purpura fulminans is a life threatening clinical entity characterized by extensive subcutaneous thrombosis and disseminated intravascular coagulation usually manifesting shortly after birth. We report an autosomal recessive form of the disease in a neonate who was diagnosed with compound heterozygosity for mutations in his protein C gene as the molecular basis of his disorder.
Krishna Sen; Angshumoy Roy
Related Documents :
18523805 - The acads gene variation spectrum in 114 patients with short-chain acyl-coa dehydrogena...
2114985 - Mechanisms of hypercholesterolaemia in glycogen storage disease type i: defective metab...
15607115 - A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin...
116095 - Nutritional assessment of the hospitalized patient.
10866065 - Simultaneous separation and quantitation of the major bovine whey proteins including pr...
19652275 - The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modifi...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Indian pediatrics     Volume:  43     ISSN:  0019-6061     ISO Abbreviation:  Indian Pediatr     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-07-05     Completed Date:  2006-09-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985062R     Medline TA:  Indian Pediatr     Country:  India    
Other Details:
Languages:  eng     Pagination:  542-5     Citation Subset:  IM    
Department of Pediatric Medicine, Park Childrens Center for Treatment and Research, 4 Gorky Terrace, Kolkata 700 019, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / therapeutic use*
Infant, Newborn
Protein C / therapeutic use*
Protein C Deficiency / complications*,  genetics
Purpura, Schoenlein-Henoch / complications,  drug therapy*
Risk Assessment
Thrombophilia / etiology*
Reg. No./Substance:
0/Anticoagulants; 0/Protein C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neonatal hyperekplexia: the Stiff-Baby syndrome.
Next Document:  Structure of the synthetase domain of human CTP synthetase, a target for anticancer therapy.